A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Clinical trial NCT06533098 · RECRUITING
Trial details
- NCT number
- NCT06533098
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2027-12-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.